In PDAC, MUC16 and MSLN expression is correlated, and this co-expression was shown to promote cell mobility and tumor invasion, especially through the activation of JNK and ERK pathways, and also through the matrix metalloproteinase (MMP)-7 activity [52,53]. The gene discussed is MUC16; the disease is neoplasm.